logo

CSCI

Cosciens Biopharma
--
--(--)
Market Open: --
--
--(--)
Post-Market: --

CSCI fundamentals

Cosciens Biopharma (CSCI) released its earnings on May 13, 2025: revenue was 1.50M (YoY +37400.00%), beat estimates; EPS was -1.16 (YoY +75.53%), missed estimates.
Revenue / YoY
1.50M
+37400.00%
EPS / YoY
-1.16
+75.53%
Report date
May 13, 2025
EPS
Revenue

Revenue & Expenses

CSCI has released its 2025 Q1 earnings report, with revenue of 1.50M, reflecting a YoY change of -27.08%, and net profit of -3.65M, showing a YoY change of -160.89%. The Sankey diagram below clearly presents CSCI's revenue sources and cost distribution.

Key Indicators

Cosciens Biopharma (CSCI) key financial stats and ratios, covering profitability, financial health, and leverage.
Cosciens Biopharma (CSCI)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Cosciens Biopharma (CSCI)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cosciens Biopharma (CSCI)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Cosciens Biopharma (CSCI) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Cosciens Biopharma (CSCI) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield